R&D
Page 1 • 5 itemsGain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
AI in European Pharmaceutical R&D: Investment & Regulatory Insights
This article delves into the transformative impact of AI on European pharmaceutical R&D, focusing on investment trends and regulatory challenges in drug development.
EMA Accelerated Assessment of Novel mRNA Vaccine Platforms for Pandemic Preparedness
The EMA is fast-tracking the evaluation of innovative mRNA vaccine platforms to bolster pandemic preparedness and improve responses to infectious diseases.
Gene Therapies for Neurological Disorders: EMA Approval Trends & Insights
This article delves into the latest EMA approval trends for gene therapies, focusing on Zolgensma and its impact on neurological disorder treatments.
EU HTA Regulation Impact: What You Need to Know for Pharma R&D
The EU HTA Regulation significantly influences Pharma R&D, affecting drug approval processes and market access for treatments like XYZ for cancer.
EU Clinical Trials Regulation 2026: Impact on Rare Disease Drug Development
The EU Clinical Trials Regulation 2026 aims to streamline processes, significantly influencing the development of drugs for rare diseases such as Duchenne Muscular Dystrophy.